Thorp, J., Clowse, M. E. B., Förger, F., Hwang, C., Dolhain, R. J. E. M., van Tubergen, A., … Hale, T. W. (2017). 692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study. In American Journal of Obstetrics and Gynecology (Vol. 216, pp. S405–S406). Elsevier BV. https://doi.org/10.1016/j.ajog.2016.11.426

Thorp, John, Megan E. B. Clowse, Frauke Förger, Caroline Hwang, Radboud J. E. M. Dolhain, Astrid van Tubergen, Laura Shaughnessy, et al. “692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study.” In American Journal of Obstetrics and Gynecology, 216:S405–6. Elsevier BV, 2017. https://doi.org/10.1016/j.ajog.2016.11.426.

Thorp J, Clowse MEB, Förger F, Hwang C, Dolhain RJEM, van Tubergen A, et al. 692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study. In: American Journal of Obstetrics and Gynecology. Elsevier BV; 2017. p. S405–6.

Thorp, John, et al. “692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study.” American Journal of Obstetrics and Gynecology, vol. 216, no. 1, Elsevier BV, 2017, pp. S405–06. Crossref, doi:10.1016/j.ajog.2016.11.426.

Thorp J, Clowse MEB, Förger F, Hwang C, Dolhain RJEM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW. 692: Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study. American Journal of Obstetrics and Gynecology. Elsevier BV; 2017. p. S405–S406.